Agent for treatment of multiple sclerosis

Details Agent for treatment of multiple sclerosis Agent for treatment of multiple sclerosis

A - Human Necessities

61

K

A61K 31/50 (2006.01) A61P 25/00 (2006.01) C07D 237/14 (2006.01)

Patent

CA 2669563

Disclosed is an orally administrable agent for prevention and/or treatment of multiple sclerosis, which is highly effective to multiple sclerosis and excellent in safety. Specifically disclosed is an agent for prevention and/or treatment of multiple sclerosis, which contains 2-benzyl-5-(4-chlorophenyl)-6-[4-(methylthio)phenyl]-2H- pyridazin-3-one or a solvate thereof as an active ingredient.

La présente invention concerne un agent à administrer par voie orale, destiné à la prévention et/ou le traitement de la sclérose en plaques, qui agit efficacement sur la sclérose en plaques et est très sûr. L'invention porte en particulier sur un agent destiné à la prévention et/ou le traitement de la sclérose en plaques, qui contient du 2-benzyl-5-(4-chlorophényl)-6-[4-(méthylthio)phényl]-2H-pyridazine-3-un ou son solvate en tant qu'ingrédient actif.

Affiliated with

Also associated with

Rating

Agent for treatment of multiple sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agent for treatment of multiple sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for treatment of multiple sclerosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1883444